| Q89747676 | A co-culture nanofibre scaffold model of neural cell degeneration in relevance to Parkinson's disease |
| Q38211382 | A mitocentric view of Parkinson's disease. |
| Q34211127 | A mitochondrial etiology of Alzheimer and Parkinson disease |
| Q38948943 | A new split-GFP-based probe reveals DJ-1 translocation into the mitochondrial matrix to sustain ATP synthesis upon nutrient deprivation |
| Q50356424 | A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network. |
| Q36890227 | AF-MSCs fate can be regulated by culture conditions |
| Q28116275 | ATP13A2 regulates mitochondrial bioenergetics through macroautophagy |
| Q37136665 | Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies. |
| Q37221070 | Advances with microRNAs in Parkinson's disease research |
| Q36608779 | Altered Skeletal Muscle Mitochondrial Proteome As the Basis of Disruption of Mitochondrial Function in Diabetic Mice |
| Q52591608 | Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease. |
| Q39301296 | Autophagy is a cell self-protective mechanism against arsenic-induced cell transformation |
| Q28390830 | Autophagy is a protective response to ethanol neurotoxicity |
| Q37782121 | Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease |
| Q35510313 | Bioenergetic origins of complexity and disease |
| Q42133537 | CHIP Is an Essential Determinant of Neuronal Mitochondrial Stress Signaling |
| Q34770689 | Cucurbitacin E has neuroprotective properties and autophagic modulating activities on dopaminergic neurons |
| Q93108820 | Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease |
| Q39978117 | Cyclosporine A Treatment Abrogates Ischemia-Induced Neuronal Cell Death by Preserving Mitochondrial Integrity through Upregulation of the Parkinson's Disease-Associated Protein DJ-1. |
| Q34399382 | DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy |
| Q47786526 | DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia. |
| Q48131019 | DJ-1 deficiency impairs synaptic vesicle endocytosis and reavailability at nerve terminals. |
| Q30527966 | DJ-1 knock-down impairs astrocyte mitochondrial function |
| Q34189590 | DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure: involvement of mitochondrial complex I assembly |
| Q39416502 | DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. |
| Q37620686 | DJ-1 protects against cell death following acute cardiac ischemia-reperfusion injury. |
| Q26785491 | Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose |
| Q38225786 | Defective autophagy in Parkinson's disease: lessons from genetics |
| Q38035191 | Defective autophagy in Parkinson's disease: role of oxidative stress. |
| Q34428732 | Defects in mitochondrial fission protein dynamin-related protein 1 are linked to apoptotic resistance and autophagy in a lung cancer model |
| Q34538482 | Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases. |
| Q35819806 | Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis |
| Q36579655 | Distinct roles in autophagy and importance in infectivity of the two ATG4 cysteine peptidases of Leishmania major |
| Q34985943 | Diversity in the regulation of autophagy and mitophagy: lessons from Parkinson's disease. |
| Q46310564 | Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease |
| Q33705939 | Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. |
| Q28071890 | Dysregulation of autophagy and mitochondrial function in Parkinson's disease |
| Q46783933 | Effects of stimulation of autophagy on the urinary excretion of biomarkers of the oxidative status |
| Q26795417 | Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics |
| Q34078603 | Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease |
| Q41918404 | Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration. |
| Q28258696 | Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1 |
| Q44435362 | Evidence of oxidative stress in young and aged DJ-1-deficient mice. |
| Q60695461 | Exploring the Role of Autophagy in the Pathogenesis of Rotenone-induced Toxicity |
| Q47393162 | Expression of DJ-1 in Neurodegenerative Disorders |
| Q30901756 | Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. |
| Q97527088 | Fine-mapping within eQTL credible intervals by expression CROP-seq |
| Q38933311 | Fluorescence-based imaging of autophagy progression by human WIPI protein detection. |
| Q51033505 | Free radicals impair the anti-oxidative stress activity of DJ-1 through the formation of SDS-resistant dimer. |
| Q94586186 | Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis |
| Q26852964 | Genetically engineered mouse models of Parkinson's disease |
| Q42368121 | Hexokinases link DJ-1 to the PINK1/parkin pathway |
| Q28392567 | How Parkinsonian toxins dysregulate the autophagy machinery |
| Q34800994 | Identification of the recognition sequence and target proteins for DJ-1 protease |
| Q34321143 | Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells |
| Q36675381 | Integration of cellular bioenergetics with mitochondrial quality control and autophagy |
| Q36711438 | Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway |
| Q83204494 | Lipocalin 2 deficiency inhibits cell proliferation, autophagy, and mitochondrial biogenesis in mouse embryonic cells |
| Q34336431 | Loss of DJ-1 does not affect mitochondrial respiration but increases ROS production and mitochondrial permeability transition pore opening |
| Q36714253 | Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit |
| Q33727623 | Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia |
| Q33627056 | Metabolic role for yeast DJ-1 superfamily proteins |
| Q37889815 | Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease |
| Q47147993 | Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease |
| Q58575955 | Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3 |
| Q55081064 | Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease. |
| Q57155833 | Mitochondrial Targeting in Neurodegeneration: A Heme Perspective |
| Q39295078 | Mitochondrial accumulation under oxidative stress is due to defects in autophagy. |
| Q93113555 | Mitochondrial biology in airway pathogenesis and the role of NRF2 |
| Q37891820 | Mitochondrial contribution to Parkinson's disease pathogenesis |
| Q38811534 | Mitochondrial control of cell bioenergetics in Parkinson's disease. |
| Q28280353 | Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease |
| Q38237889 | Mitochondrial dynamic changes in health and genetic diseases |
| Q35799161 | Mitochondrial dynamics and Parkinson's disease: focus on parkin |
| Q41664833 | Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein? |
| Q36082495 | Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases |
| Q38021396 | Mitochondrial dynamics: the intersection of form and function |
| Q27014051 | Mitochondrial dysfunction and oxidative stress in Parkinson's disease |
| Q36590693 | Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism |
| Q58693945 | Mitochondrial dysfunction in Parkinson's disease |
| Q38021865 | Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences |
| Q90306382 | Mitochondrial fragmentation and network architecture in degenerative diseases |
| Q92365106 | Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients |
| Q37726096 | Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1. |
| Q35799128 | Mitochondrial quality control and dynamics in Parkinson's disease |
| Q28395762 | Mitochondrial stress signaling promotes cellular adaptations |
| Q92129107 | Mitophagy in Parkinson's Disease: From Pathogenesis to Treatment |
| Q37957494 | Modelling of Parkinson's disease in mice |
| Q36747314 | Molecular events underlying Parkinson's disease - an interwoven tapestry |
| Q34988753 | Molecular insights into Parkinson's disease |
| Q34552123 | Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants |
| Q91859559 | Mutations in RHOT1 Disrupt Endoplasmic Reticulum-Mitochondria Contact Sites Interfering with Calcium Homeostasis and Mitochondrial Dynamics in Parkinson's Disease |
| Q64110751 | Natrium Benzoate Alleviates Neuronal Apoptosis via the DJ-1-Related Anti-oxidative Stress Pathway Involving Akt Phosphorylation in a Rat Model of Traumatic Spinal Cord Injury |
| Q36899553 | Neuroprotective function of DJ-1 in Parkinson's disease |
| Q44083491 | Novel glyoxalases from Arabidopsis thaliana |
| Q24337858 | Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death |
| Q26798897 | Oxidative stress and Parkinson's disease |
| Q42416499 | Oxygen-glucose-deprived rat primary neural cells exhibit DJ-1 translocation into healthy mitochondria: a potent stroke therapeutic target |
| Q61875301 | Paraquat: Molecular Mechanisms of Neurotoxicity and its Relation with Autophagy |
| Q26781796 | Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection |
| Q37087927 | Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction |
| Q40393851 | Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells. |
| Q35032823 | Parkinson's disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein. |
| Q33871291 | Parkinson's disease: insights from pathways |
| Q36186542 | Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways |
| Q37497833 | Pharmacological approaches to restore mitochondrial function |
| Q38036233 | Programmed cell death in Parkinson's disease |
| Q36939061 | Proteome Profile and Quantitative Proteomic Analysis of Buffalo (Bubalusbubalis) Follicular Fluid during Follicle Development |
| Q37502060 | Proteomic Analysis Reveals the Positive Roles of the Plant-Growth-Promoting Rhizobacterium NSY50 in the Response of Cucumber Roots to Fusarium oxysporum f. sp. cucumerinum Inoculation |
| Q90102147 | Reactive Metabolite-induced Protein Glutathionylation: A Potentially Novel Mechanism Underlying Acetaminophen Hepatotoxicity |
| Q34189660 | Recent advances in the genetics of Parkinson's disease |
| Q58716523 | Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contacts |
| Q47393112 | Regulation of Signal Transduction by DJ-1. |
| Q38264531 | Regulation of autophagy by protein post-translational modification |
| Q37998247 | Review: quantifying mitochondrial dysfunction in complex diseases of aging. |
| Q96953595 | Role of DJ-1 in Immune and Inflammatory Diseases |
| Q64980081 | Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease. |
| Q64762196 | Role of GTPases in the regulation of mitochondrial dynamics in Parkinson's disease |
| Q38757045 | SUMO-regulated mitochondrial function in Parkinson's disease |
| Q35857121 | Schizosaccharomyces pombe Homologs of Human DJ-1 Are Stationary Phase-Associated Proteins That Are Involved in Autophagy and Oxidative Stress Resistance |
| Q38769351 | The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity |
| Q55384244 | The Oxygen Paradox, the French Paradox, and age-related diseases. |
| Q38374332 | The Parkinson Disease Mitochondrial Hypothesis: Where Are We at? |
| Q48158987 | The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering |
| Q39138747 | The Parkinson's disease-associated gene PINK1 protects neurons from ischemic damage by decreasing mitochondrial translocation of the fission promoter Drp1. |
| Q35031181 | The Role of Cysteine Oxidation in DJ-1 Function and Dysfunction |
| Q64069200 | The Role of the Antioxidant Response in Mitochondrial Dysfunction in Degenerative Diseases: Cross-Talk between Antioxidant Defense, Autophagy, and Apoptosis |
| Q38202314 | The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease |
| Q26853454 | The dynamics of the mitochondrial organelle as a potential therapeutic target |
| Q47646796 | The genetic architecture of mitochondrial dysfunction in Parkinson's disease |
| Q38016276 | The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease |
| Q34807191 | The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble |
| Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
| Q24307946 | The role of oxidative stress in Parkinson's disease |
| Q36375135 | The use of primary human fibroblasts for monitoring mitochondrial phenotypes in the field of Parkinson's disease |
| Q39264622 | Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes |
| Q37704828 | Two novel compound heterozygous mutations in OPA3 in two siblings with OPA3-related 3-methylglutaconic aciduria |
| Q37775037 | Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy |
| Q51716269 | Unexpected mitochondrial matrix localization of Parkinson's disease-related DJ-1 mutants but not wild-type DJ-1. |
| Q34201811 | Unravelling the role of defective genes |
| Q92328689 | Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson's Disease Patients |
| Q37796006 | What have we learned from Drosophila models of Parkinson’s disease? |
| Q27937729 | Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase |
| Q40986110 | αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease. |